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Abstract—The antitumor macrolide aplyronine A induces protein–protein interaction (PPI) between actin and tubulin to exert highly potent 
biological activities. The interactions and binding kinetics of these molecules were analyzed by the surface plasmon resonance with 
biotinylated aplyronines or tubulin as ligands. Strong binding was observed for tubulin and actin with immobilized aplyronine A. These PPIs 
were almost completely inhibited by one equivalent of either aplyronine A or C, or mycalolide B. In contrast, a non-competitive actin-
depolymerizing agent, latrunculin A, highly accelerated their association. Significant binding was also observed for immobilized tubulin with 
an actin–aplyronine A complex, and the dissociation constant KD was 1.84 µM. Our method could be used for the quantitative analysis of the 
PPIs between two polymerizing proteins stabilized with small agents.    © 2016 Elsevier Science. All rights reserved 
1. Introduction 
 Aplyronine A (1) is a 24-membered macrolide that was 
isolated from the sea hare Aplysia kurodai (Figure 1).1–3 It 
bears a C24–C34 side chain moiety that includes a terminal 
N-methyl enamide group and two amino acid esters (N,N,O-
trimethylserine and N,N-dimethylalanine) as structural 
features. Aplyronine A exhibits strong cytotoxicity against 
HeLa S3, a human cervical carcinoma cell line (IC50 10 pM), 
and potent antitumor activities against several murine 
xenograft models. Previous studies have shown that 
aplyronine A (1) inhibits actin polymerization by forming a 
1:1 complex with the globular monomeric molecule.4 X-ray 
analysis of the actin–aplyronine A complex revealed that 1 
intercalates into the hydrophobic cleft between subdomains 
(SD) 1 and 3 of actin by using its side chain.5 
 Recent target identification studies using the 
photoaffinity derivatives and other biochemical experiments 
have established that aplyronine A (1) synergistically binds 
to tubulin in association with actin.6 Several tubulin-
targeting natural products, which regulate spindle 
microtubule dynamics, have been widely used in cancer 
chemotherapy. To our knowledge, aplyronine A (1) is the 
first molecule to be known to promote the protein–protein 
interactions (PPIs) between tubulin and actin to exert highly 
potent biological activities.7,8 However, little is known about 
their intermolecular interactions and binding kinetics. 
Several biochemical techniques that can be used to discover 
and characterize PPI modulators have been established; e.g., 
enzyme-linked immunosorbent assays (ELISA), 
fluorescence resonance energy transfer (FRET) and related 
proximity-based methods, and surface plasmon resonance 
(SPR).9,10 To further analyze the binding kinetics and 
stabilizing effect of 1 for the PPIs between actin and tubulin, 
in the present study we conducted a biosensor SPR analysis 
of aplyronines.  
2. Results and Discussion 
2.1. Preparation of aplyronine biotin derivatives and 
their interactions with actin  
 To immobilize aplyronines on a streptavidin sensor chip, 
we used their biotin derivatives. The PEG-linked aplyronine 
A biotin conjugate 3 has been used for target identification 
studies.11 We also used aplyronine C (2), a natural congener 
of 1 that lacks the C7 trimethylserine ester moiety, as a 
negative control.12,13 It exhibits as much actin-
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depolymerizing activity as 1, but is 1,700 times less 
cytotoxic due to its inability to interact with tubulin. Thus, 
we prepared an aplyronine C biotin derivative 4 from 2 
(Figure S1). Aplyronine C analog 4 was found to be 7,300 
times less cytotoxic against HeLa S3 cells than 3 (IC50 = 700 
nM), which reflected the significant difference in 
cytotoxicity between the natural aplyronines.  
 
 
 
Figure 1. Structures of aplyronines and their biotin derivatives. IC50 values 
for cytotoxicity against HeLa S3 cells are shown below each compound (to 
the right). 
 
 To investigate the interactions between actin and 
aplyronines, biotin derivatives 3 and 4 were used as ligands 
for SPR analysis. Strong binding was observed for actin with 
ligand 3 on the surface (Figure 2A). The equilibrium 
constants obtained from global kinetic fitting of the 
sensorgrams were then fitted to an approximate 1:1 model 
(Figure S2). The on-rate constant ka was determined to be 
4.54 × 103 M–1 s–1, while the off-rate constant kd was 0.0183 
s–1, which makes this ligand 3 a moderate actin binder in this 
set (KD 4.02 × 10–6 M) (Table 1). Under the same conditions, 
ligand 4 bound to actin with a similar off-rate constant kd as 
3, but with an approximately five-hold smaller on-rate 
constant ka, which led to a substantial decrease in association 
(KD 1.80 × 10–5 M). The KD value for actin and 1 has been 
reported to be 1.0 × 10–7 M, based on a fluorescent actin-
polymerization inhibitory assay.4 These decreases in affinity 
with actin might be due to modification of the side chain 
moiety in 3. 
Table 1.  Binding kinetics of immobilized aplyronines–actin 
interaction  
ligand     kd (s
–1)            ka (M
–1 s–1)       KD 
(M) 
    3 1.83 × 10–2           4.54 × 103        4.02 × 
10–6  
    4 1.51 × 10–2           8.38 × 102        1.80 × 
10–5  
a Values were determined by global fitting of five concentrations of 
analyte (actin) as shown in Figure 2A. 
 
2.2. Interactions of actin and tubulin with immobilized 
aplyronine A  
 Next, interactions of actin and tubulin with immobilized 
aplyronine A were analyzed by SPR. By using biotinylated 
aplyronine A as a ligand, actin and tubulin were 
simultaneously injected. However, no meaningful SPR 
responses were observed despite the strong interactions 
between actin and immobilized aplyronine A as mentioned 
above. After several attempts, however, strong binding was 
observed for tubulin and actin with immobilized aplyronine 
A when actin was loaded in advance and actin and tubulin 
were continuously co-injected (Figure 2B). Tubulin binding 
was concentration-dependent (0 to 2 µM) (Figure S3). On 
the other hand, no significant binding was observed when 
tubulin alone was injected over the actin-preloaded surface. 
Since actin is unstable in the tubulin-stabilizing PIPES–KCl 
buffer supplemented in the running buffer for the second 
injection, preloaded actin might rapidly dissociate from the 
surface or lose the ability to bind to tubulin via aplyronine A.  
 To demonstrate the binding specificity of PPIs between 
actin and tubulin, various actin-targeting agents were co-
injected with actin and tubulin (Figure 2C). Mycalolide B is 
an actin-depolymerizing agent that interacts with the same 
binding site of actin as aplyronines.14 The KD value for actin 
and mycalolide B has been reported to be 13–20 nM.15,16 As 
expected, one equivalent each of aplyronines A (1) and C (2) 
and mycalolide B almost completely inhibited the 
interaction of tubulin with the actin–aplyronine A complex 
on the surface. In contrast, an excess amount of latrunculin 
A, another actin-depolymerizing agent that binds to the 
ATP-binding site of actin (opposite site for aplyronines), 
highly enhanced the association of actin and tubulin onto the 
aplyronine A-immobilized chip (ca. 70% increase in RU). 
Previous ultracentrifugation experiments and gel-
permeation HPLC analysis suggested that monomeric actin 
assembles and loses its function under high Mg2+ 
conditions.6 In fact, the loading of actin in the PIPES–KCl-
enriched buffer increased the bulk response, presumably due 
to the unspecific binding of actin oligomers (Figure 2B). 
Thus, latrunculin A might increase the effective 
concentration of monomeric actin in the tubulin-stabilizing 
buffer, which significantly enhanced the formation of the 
actin–aplyronine A–tubulin ternary complex. Even in the 
presence of latrunculin A, however, the dissociation of two 
proteins was too fast to calculate the binding kinetics for the 
actin–aplyronine A–tubulin ternary complex. 
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Figure 2. Interactions of actin and tubulin with immobilized aplyronines as monitored by SPR. (A) Ligands: biotin derivatives 3 and 4. Various concentrations 
of actin (0 to 125 nM) were injected over the surface for 3 min in the running buffer supplemented with 10% of 10 × G-buffer [final concentrations: 2 mM 
Tris·HCl (pH 8.0), 0.2 mM CaCl2, 0.2 mM ATP, 0.5 mM 2-mercaptoethanol]. After the injection, the running buffer supplemented with G-buffer was 
continuously introduced onto the sensor surface for 3 min. (B, C) Ligand: biotin derivative 3. Actin (1 µM) was injected over the surface for 3 min in the 
running buffer supplemented with G-buffer (black arrow). In (B), tubulin and/or actin (1 µM each) were then continuously injected for 3 min in the running 
buffer supplemented with 20% of 5 × PIPES–KCl buffer [final concentrations: 50 mM PIPES (pH 6.9), 10 mM MgCl2, 0.1 M KCl] (red arrow). In (C), tubulin 
and actin (1 µM each) with various actin-depolymerizing agents were continuously injected for 3 min. 
  
2.3. Interaction of biotinylated tubulin with actin–
aplyronine A complex  
 Next, we planned to use biotinylated tubulin as a ligand 
for SPR analysis. To establish whether this modified tubulin 
specifically interacts with the actin–aplyronine A complex, 
an in vitro ultracentrifugation experiment was carried out. 
Aplyronine A (1) induced microtubule disassembly in the 
presence of actin, and both these proteins were dominantly 
detected in the supernatant (lanes 1 and 4, Figure 3A). In 
contrast, only actin moved to the supernatant under 
treatment with aplyronine C (2) (lanes 2 and 5). Under 
similar conditions using a 9:1 mixture of tubulin/biotinylated 
tubulin, both tubulin and actin moved to the supernatant 
under treatment with 1, as in the experiments with native 
tubulin. Western blotting analysis using HRP-conjugated 
streptavidin revealed that ca. 65% of the biotinylated tubulin 
was contained in the supernatant fraction, which is 
consistent with the results of CBB staining. These results 
suggested that actin and 1 synergistically depolymerize 
microtubules that contain biotinylated tubulin.  
 To establish the interaction of biotinylated tubulin with 
the actin–aplyronine A complex, we performed a gel-
permeation HPLC analysis (Figure 3B). Native tubulin and 
biotinylated tubulin were eluted in PIPES–KCl buffer at 
almost the same time (black trace), which corresponded to 
the /-tubulin heterodimer (16.8 min, 100 kDa). When 
actin, 1, and a 9:1 mixture of tubulin/biotinylated tubulin 
were co-analyzed, two mobility peaks were detected (gray 
trace), which corresponded to a 1:1:1 complex of 
actin−aplyronine A−tubulin heterodimer (15.9 min, 145 
 Bioorganic & Medicinal Chemistry 2 
kDa) and the liberated actin–aplyronine A complex (18.5 
min, 45 kDa), respectively. These elution patterns were 
similar to the previous experiments using native tubulin.6 
SDS-PAGE analysis revealed that the elution of the ternary 
complex containing biotinylated tubulin overlapped that of 
native tubulin. These results strongly indicated that 
biotinylated tubulin can form a ternary complex with actin 
and 1. 
2.4. Interactions of the actin and tubulin complex with 
aplyronine A  
 Due to the instability of diluted tubulin in vitro, 
biotinylated tubulin was immobilized on the streptavidin 
surface of a sensor chip in the presence of a 20-fold higher 
concentration of native tubulin in PIPES–KCl buffer 
(3600~3700 RU) (Figure S4). Since a significant reduction 
in the SPR signals was observed with the repeated injection 
of analyte and over time, actin and 1 were immediately co-
injected after tubulin immobilization, and only the first-run 
sensorgram was used for each analysis. As a result, the PPI 
of actin and tubulin with 1 was detected in a concentration-
dependent manner (Figure 4). The equilibrium constants 
obtained from global kinetic fitting of the sensorgrams were 
then fitted to an approximate 1:1 model (Figure S2).17 The 
on- and off-rate constants ka and kd of the actin–aplyronine 
A complex to tubulin heterodimer were determined to be 
4.78 × 104 M–1 s–1 and 8.82 × 10‒2 s‒1, respectively, and thus 
their dissociation constant KD was 1.84 × 10–6 M at 25 °C.18  
 
 
Figure 3. Interaction of biotinylated tubulin with actin–aplyronine A complex. (A) In vitro microtubule depolymerization assay. Tubulin (with or without 10% 
biotinylated tubulin) was polymerized with paclitaxel in the presence of actin and aplyronines, and then precipitated by ultracentrifugation. Proteins in the 
supernatant and the precipitate were analyzed by SDS-PAGE, and detected with CBB stain and HRP-conjugated streptavidin. (B) Gel-permeation HPLC 
analysis. A 9:1 mixture of tubulin/biotinylated tubulin with (gray trace) or without (black trace) actin and 1 were analyzed. Buffer, 50 mM PIPES·K (pH 6.8), 
10 mM MgCl2, 0.1 M KCl; column, TSKgel SuperSW3000 ( 4.6 × 300 mm); flow rate, 0.2 mL/min; temp., 12 °C; detection, UV 280 nm. Eluted proteins 
(fractions 1–10) were analyzed by SDS-PAGE under reducing conditions and detected with CBB stain or HRP-conjugated streptavidin (bottom).   
  
 Previous gel-permeation HPLC studies at 8 °C showed 
that the association constant KA of the actin−aplyronine A 
complex to tubulin heterodimer was 3.0 × 106 M–1,6 which 
reflects an approximately six-fold higher affinity than this 
SPR analysis. This difference in affinity on these two 
analyses might be explained by the modification of tubulin 
and/or the thermal instability of the actin–aplyronine A–
tubulin ternary complex at 25 °C on SPR. Meanwhile, no 
significant binding was observed for the actin−aplyronine C 
complex with immobilized tubulin (Figure S5). These results 
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were consistent with previous findings that the actin–
aplyronine C complex did not attenuate microtubule growth 
in vitro, and that treatment with 2 had no detectable effects 
on spindle formation in tumor cells. Notably, the SPR 
response for the formation of a ternary complex induced by 
1 was highly specific. It has not been established how 
aplyronine A forms the ternary complex with actin and 
tubulin in cells. However, in vitro assay, aplyronine A binds 
to actin to form the 1:1 complex. Also, only in the presence 
of actin, it binds to tubulin, inhibits microtubule dynamics, 
and forms the 1:1:1 heterotrimetric complex. Thus, we 
expected that aplyronine A interacts with actin prior to 
tubulin.   
 
 
Figure 4. Interactions of the actin and tubulin complex with aplyronine A 
monitored by SPR. Ligand: biotinylated tubulin. Various concentrations of 
actin (0 to 1 µM) with 1 (2 eq. for actin) as analytes were injected over the 
surface for 3 min in PIPES–KCl buffer. After the injection, PIPES–KCl 
buffer was continuously introduced onto the sensor surface for 3 min.  
 
3. Conclusion  
 In summary, we have established the kinetics of PPI 
between the two polymerizing labile proteins, actin and 
tubulin, stabilized with an antitumor macrolide aplyronine A. 
SPR analysis also revealed that several actin-targeting 
agents specifically interfere with the PPIs including actin. 
Actin and tubulin are representative cytoskeleton proteins 
that are essential for eukaryote cellular systems. The 
assembly of both actin filaments and microtubules is highly 
regulated by numerous endogenous binding proteins. Thus, 
our methodology might contribute to the discovery and 
characterization of key compounds that regulate such 
multiple protein dynamics. Our study should promote further 
biological and pharmacological investigations of various 
cytoskeleton-targeting agents that show unique mechanisms 
of action as well as microtubule-targeting antitumor drugs.  
4. Experimental  
4.1. General  
 Aplyronine A (1) was isolated from the sea hare Aplysia 
kurodai, as described previously.1 Aplyronine C (2) and 
aplyronine A biotin conjugate (3) were prepared from 
natural 1.11,12 Other actin- and microtubule-targeting agents 
were purchased from Wako Chemical Co. unless noted 
otherwise. Rabbit skeletal muscle actin and biotinylated 
tubulin from porcine brain were purchased from 
Cytoskeleton Inc. Native tubulin was prepared from porcine 
brain using high-molarity buffer according to the literature.19 
High-resolution electrospray ionization mass spectra (HR-
ESIMS) were measured on an AccuTOF CS spectrometer 
(JEOL). 
4.2. Preparation of aplyronine C biotin conjugate (4) 
 To a stirred solution of aplyronine C (2) (95 µg, 100 
nmol) in 1,4-dioxane (0.3 mL) was added 2 M aq. HCl (0.1 
mL) under a nitrogen atmosphere. After being stirred for 80 
min at 50 °C, the reaction mixture was neutralized with 
sodium bicarbonate (3 mL) and extracted with chloroform (2 
mL × 4). The combined extracts were washed with brine and 
concentrated to give aldehyde 5, which was used for the next 
step without further purification. To a stirred solution of 5 in 
methanol–acetic acid (4:1, 0.2 mL) was added EZ-Link 
Biotin-PEG4-Hydrazide (2.5 µmol, Thermo Scientific) in 
DMSO (10 µL) under a nitrogen atmosphere. After the 
mixture was stirred for 60 h at room temperature, acetone 
(50 µL) was added. After additional stirring for 30 min, the 
reaction mixture was azeotropically concentrated with 
toluene and applied to a Develosil ODS-HG-5 reversed-
phase HPLC column ( 4.6 mm I.D. × 250 mm, Nomura 
Chemical Co.). Samples were eluted by methanol / 40 mM 
ammonium acetate (73:27) at a flow rate of 1 mL/min, with 
monitoring at 254 nm, and then lyophilized from water twice 
to give aplyronine C biotin conjugate (4) (27 nmol, 27% in 
2 steps, based on the HPLC analysis compared with 3, tR = 
10.4 min).  
4.2.1. Aplyronine C biotin conjugate (4). HRMS (ESI) m/z 
1415.8582 (calcd for C72H124N6NaO18S [M+Na]+, ∆ −0.3 
mmu). 
4.3. Cell culture and cytotoxicity assay  
 HeLa S3 cells (ATCC CCL-2.2) were cultured in Eagle’s 
minimal essential medium (E-MEM) supplemented with 
10% fetal bovine serum in a humidified atmosphere 
containing CO2 (5%). Cells were seeded at 2 × 103 cells per 
well in 96-well plates. After incubation overnight at 37 °C, 
samples in DMSO were added, and the cells were incubated 
for 96 h at 37 °C. 1.4 mg/mL 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) solution in 
phosphate buffer saline (PBS) (50 µL) was added to the cells. 
After 4 h, the culture medium was removed and the formazan 
product was dissolved in DMSO (150 μL). Optical density 
at 540 nm was measured with a TECAN microplate reader 
(Infinite® 200 Pro). All assays were performed in duplicate 
to confirm reproducibility. 
4.4. Surface plasmon resonance (SPR) analysis  
 A Biacore 2000 (GE Healthcare) was used to analyze 
molecular interactions by means of SPR spectroscopy. All 
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analyses were conducted at 25 °C and with a flow rate of 10 
µL/min in the general running buffer [20 mM HEPES (pH 
7.4), 0.15 M NaCl, 3.4 mM EDTA, 0.05% surfactant P20, 
pH 7.4] unless noted otherwise. Biotinylated ligands or 
proteins were immobilized on the surface of a sensor chip 
SA (streptavidin). For biotinylated ligands 3 and 4, a surface 
density of 300~350 RU was generated by loading 10 µM 
analytes for 1 min. For biotinylated tubulin, a surface density 
of 3600~3700 RU was generated by loading 1 µM 
biotinylated tubulin with 20 µM native tubulin for 7 min in 
PIPES–KCl buffer with a flow rate of 15 µL/min. Each 
sensorgram (time-course of the SPR signal) was corrected 
for the response observed in the control ﬂow cell and 
normalized to a baseline of 0 RU. The association and 
dissociation rate constants were calculated by using Biacore 
2000 Evaluation software (version 2.0.1). 
4.5. Microtubule sedimentation assay  
 Tubulin (3 µM as a heterodimer) in modified RB buffer 
[100 mM PIPES·Na (pH 6.9), 1 mM EGTA, 2 mM MgCl2] 
was ultracentrifuged (150,000 × g, 30 min, 4 °C) to remove 
oligomeric tubulins. To the supernatants (500 µL) were 
added 2 mM paclitaxel in DMSO (0.75 µL) to induce 
microtubule formation, with or without 100 µM actin in G-
buffer (15 µL) and 1 mM aplyronines (1.5 µL). After 
incubation for 1 h at 37 °C, samples were ultracentrifuged 
(150,000 × g, 1 h, 37 °C). The supernatants (lyophilized) and 
precipitates were dissolved in 1 × SDS buffer (100 µL) and 
boiled for 5 min at 95 °C. SDS-PAGE was performed using 
a precast 10% polyacrylamide gel, and the gels were stained 
with a Quick-CBB kit (Wako). For immunoblot analyses, 
proteins in the gels after electrophoresis were transferred to 
PVDF membranes, using the Trans-Blot® SD semi-dry 
blotting system (Bio-Rad). Proteins were detected with 
HRP-conjugated streptavidin (1:3000, cat. no. RPN1231v, 
GE Healthcare). The HRP-conjugated bands were visualized 
with an ECL-prime system (GE Healthcare), and detected by 
a Fujifilm LAS-4000 MINI imaging scanner. 
4.6. Gel permeation HPLC analysis of the actin–ApA–
tubulin complex 
 Actin, aplyronines, and tubulin heterodimer were mixed 
at a 1:1:1 molar ratio (50 µM each). After incubation at room 
temperature for 10 min, 5 µL of the mixture was analyzed 
by gel permeation column chromatography on a TSKgel 
SuperSW3000 column (TOSOH Co.), as described 
previously.6  
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